SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/07/21 Accolade, Inc. 10-K 2/28/21 103:10M Toppan Merrill Bridge/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.55M 2: EX-4.6 Instrument Defining the Rights of Security Holders HTML 41K 3: EX-10.13 Material Contract HTML 62K 4: EX-21.1 Subsidiaries List HTML 29K 5: EX-23.1 Consent of Expert or Counsel HTML 28K 6: EX-31.1 Certification -- §302 - SOA'02 HTML 31K 7: EX-31.2 Certification -- §302 - SOA'02 HTML 31K 8: EX-32.1 Certification -- §906 - SOA'02 HTML 30K 15: R1 Document and Entity Information HTML 93K 16: R2 Consolidated Balance Sheets HTML 119K 17: R3 Consolidated Balance Sheets (Parenthetical) HTML 52K 18: R4 Consolidated Statements of Operations HTML 75K 19: R5 Consolidated Statements of Convertible Preferred HTML 154K Stock and Stockholders' Equity (Deficit) 20: R6 Consolidated Statements of Convertible Preferred HTML 31K Stock and Stockholders' Equity (Deficit) (Parenthetical) 21: R7 Consolidated Statements of Cash Flows HTML 133K 22: R8 Background HTML 36K 23: R9 Summary of Significant Accounting Policies HTML 113K 24: R10 Acquisition of MD Insider (Mdi) HTML 53K 25: R11 Property and Equipment HTML 50K 26: R12 Accrued Expenses and Accrued Compensation HTML 46K 27: R13 Fair Value Measurements HTML 67K 28: R14 Debt Facility HTML 49K 29: R15 Stockholders' Equity (Deficit) HTML 79K 30: R16 Stock Options and Warrants HTML 144K 31: R17 Defined Contribution Retirement Plan HTML 31K 32: R18 Income Taxes HTML 141K 33: R19 Net Loss Per Share Attributable to Common HTML 57K Stockholders 34: R20 Commitments HTML 44K 35: R21 Change Healthcare Joint Development Agreement HTML 42K 36: R22 Related Party Transactions HTML 31K 37: R23 Subsequent Events HTML 36K 38: R24 Summary of Significant Accounting Policies HTML 166K (Policies) 39: R25 Summary of Significant Accounting Policies HTML 69K (Tables) 40: R26 Acquisition of MD Insider (Mdi) (Tables) HTML 52K 41: R27 Property and Equipment (Tables) HTML 48K 42: R28 Accrued Expenses and Accrued Compensation (Tables) HTML 43K 43: R29 Fair Value Measurements (Tables) HTML 65K 44: R30 Debt facility (Tables) HTML 36K 45: R31 Stockholders' Equity (Deficit) (Tables) HTML 70K 46: R32 Stock Options and Warrants (Tables) HTML 140K 47: R33 Income Taxes (Tables) HTML 139K 48: R34 Net Loss Per Share Attributable to Common HTML 58K Stockholders (Tables) 49: R35 Commitments (Tables) HTML 39K 50: R36 Change Healthcare Joint Development Agreement HTML 37K (Tables) 51: R37 Background - Initial Public Offering (Details) HTML 61K 52: R38 Summary of Significant Accounting Policies - HTML 40K Useful lives for property and equipment (Details) 53: R39 Summary of Significant Accounting Policies - HTML 37K Capitalized Internal-Use Software Costs (Details) 54: R40 Summary of Significant Accounting Policies - HTML 38K Intangible Assets (Details) 55: R41 Summary of Significant Accounting Policies - HTML 43K Revenue and Deferred Revenue (Details) 56: R42 Summary of Significant Accounting Policies - HTML 32K Revenue and Deferred Revenue Narratives (Details) 57: R43 Summary of Significant Accounting Policies - Cost HTML 51K to obtain and fulfill a contract (Details) 58: R44 Summary of Significant Accounting Policies - HTML 49K Concentration of Credit Risk (Details) 59: R45 Summary of Significant Accounting Policies - HTML 41K Additional Information (Details) 60: R46 Summary of Significant Accounting Policies - HTML 30K Deferred Offering Costs (Details) 61: R47 Summary of Significant Accounting Policies - HTML 33K Unaudited Pro Forma Financial Information - (Details) 62: R48 Acquisition of MD Insider (MDI) - Summary of HTML 55K Purchase Consideration (Details) 63: R49 Acquisition of MD Insider (MDI) - Summary of HTML 64K Estimated Fair Values of Assets Acquired and Liabilities Assumed (Details) 64: R50 Property and Equipment (Details) HTML 58K 65: R51 Accrued Expenses and Accrued Compensation HTML 42K (Details) 66: R52 Accrued Expenses and Accrued Compensation - HTML 48K Additional Information (Details) 67: R53 Fair Value Measurements (Details) HTML 39K 68: R54 Debt facility (Details) HTML 90K 69: R55 Debt facility - Long-Term Debt (Details) HTML 37K 70: R56 Debt facility - Warrant Rights (Details) HTML 79K 71: R57 Stockholders' Equity (Deficit) - Convertible HTML 83K Preferred Stock (Details) 72: R58 Stockholders' Equity (Deficit) - Additional HTML 72K Information (Details) 73: R59 Stockholders' Equity (Deficit) - Common Stock HTML 42K (Details) 74: R60 Stock Options and Warrants - Shares (Details) HTML 69K 75: R61 Stock Options and Warrants - Compensation expense HTML 43K (Details) 76: R62 Stock Options and Warrants - Fair value of common HTML 48K stock (Details) 77: R63 Stock Options and Warrants - Award Option HTML 75K (Details) 78: R64 Stock Options and Warrants - Restricted Stock HTML 63K Units (Details) 79: R65 Stock Options and Warrants - Common Stock Warrants HTML 71K (Details) 80: R66 Stock Options and Warrants - Common Stock Warrants HTML 37K - Summary of activity - (Details) 81: R67 Stock Options and Warrants - Equity - (Details) HTML 51K 82: R68 Defined Contribution Retirement Plan - Additional HTML 38K Information (Details) 83: R69 Income Taxes - Components of loss before income HTML 37K taxes (Details) 84: R70 Income Taxes - Significant components of income HTML 48K taxes (Details) 85: R71 Income Taxes - Reconciliation of income tax HTML 46K expense at U.S. Federal statutory income tax rate (Details) 86: R72 Income Taxes - Significant components of the HTML 57K Company's deferred tax assets and liabilities (Details) 87: R73 Income Taxes - Operating loss carryforwards HTML 40K (Details) 88: R74 Income Taxes - Tax credit carryforwards (Details) HTML 31K 89: R75 Income Taxes - Changes in deferred tax, valuation HTML 34K allowance (Details) 90: R76 Income Taxes - Additional Information (Details) HTML 33K 91: R77 Income Taxes - Tax Act (Details) HTML 30K 92: R78 Net Loss Per Share Attributable to Common HTML 41K Stockholders (Details) 93: R79 Net Loss Per Share Attributable to Common HTML 39K Stockholders - Stock Options (Details) 94: R80 Commitments - Future minimum lease payments HTML 57K (Details) 95: R81 Commitments - Legal Proceedings (Details) HTML 38K 96: R82 Change Healthcare Joint Development Agreement HTML 59K (Details) 97: R83 Change Healthcare Joint Development Agreement - HTML 40K Future data license fee payments (Details) 98: R84 Related Party Transactions (Details) HTML 38K 99: R85 Subsequent Events (Details) HTML 76K 101: XML IDEA XML File -- Filing Summary XML 189K 14: XML XBRL Instance -- accd-20210228x10k_htm XML 2.23M 100: EXCEL IDEA Workbook of Financial Reports XLSX 125K 10: EX-101.CAL XBRL Calculations -- accd-20210228_cal XML 205K 11: EX-101.DEF XBRL Definitions -- accd-20210228_def XML 769K 12: EX-101.LAB XBRL Labels -- accd-20210228_lab XML 1.70M 13: EX-101.PRE XBRL Presentations -- accd-20210228_pre XML 1.30M 9: EX-101.SCH XBRL Schema -- accd-20210228 XSD 224K 102: JSON XBRL Instance as JSON Data -- MetaLinks 439± 688K 103: ZIP XBRL Zipped Folder -- 0001558370-21-006527-xbrl Zip 408K
Download this zipped .zip folder | |
Files: | accd-20210228.xsd accd-20210228_cal.xml accd-20210228_def.xml accd-20210228_lab.xml accd-20210228_pre.xml accd-20210228x10k.htm accd-20210228x10k003.jpg accd-20210228xex10d13.htm accd-20210228xex21d1.htm accd-20210228xex23d1.htm accd-20210228xex31d1.htm accd-20210228xex31d2.htm accd-20210228xex32d1.htm accd-20210228xex4d6.htm |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/26/24 Accolade, Inc. S-8 4/26/24 4:141K 4/26/24 Accolade, Inc. 10-K 2/29/24 98:9.3M 4/28/23 Accolade, Inc. 10-K 2/28/23 103:11M Toppan Merrill Bridge/FA 4/28/23 Accolade, Inc. S-8 4/28/23 4:90K Toppan Merrill/FA 6/03/22 Accolade, Inc. S-8 6/03/22 4:87K Toppan Merrill/FA 5/02/22 Accolade, Inc. 10-K 2/28/22 102:12M Toppan Merrill Bridge/FA 7/09/21 Accolade, Inc. S-3ASR 7/09/21 7:1.3M Toppan Merrill/FA 7/08/21 Accolade, Inc. 10-Q 5/31/21 67:6.9M Toppan Merrill Bridge/FA 6/10/21 Accolade, Inc. S-8 6/10/21 5:564K Toppan Merrill/FA 5/11/21 Accolade, Inc. POS AM 2:707K Toppan Merrill/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/01/21 Accolade, Inc. S-1/A 4:3.7M Toppan Merrill/FA 3/29/21 Accolade, Inc. 8-K:1,2,3,8 3/23/21 14:1.3M Toppan Merrill/FA 3/15/21 Accolade, Inc. S-1 143:13M Toppan Merrill/FA 3/04/21 Accolade, Inc. 8-K:1,3,8,9 3/03/21 13:1.5M Toppan Merrill/FA 11/09/20 Accolade, Inc. 8-K:1,9 11/06/20 11:245K Toppan Merrill/FA 10/14/20 Accolade, Inc. 10-Q 8/31/20 64:5.9M Toppan Merrill Bridge/FA 8/25/20 Accolade, Inc. 8-K:1,9 8/21/20 11:269K Toppan Merrill Bridge/FA 7/10/20 Accolade, Inc. 8-K:5,9 7/07/20 2:58K Toppan Merrill/FA 6/24/20 Accolade, Inc. S-1/A 5:5.7M Toppan Merrill-FA 6/16/20 Accolade, Inc. S-1/A 10:7.8M Toppan Merrill-FA 2/28/20 Accolade, Inc. S-1 39:24M Toppan Merrill-FA |